Unmasking the Silent Threat: Prevalence of Cardiovascular Risk Factors in MS Patients in Bucharest, Romania

Florentina Cristina Pleșa1, Elena Andreea Arsene2, Andreea Pleșa3

  • 1Clinical Neurosciences Department, 'Carol Davila' University of Medicine and Pharmacy, 050474 Bucharest, Romania.

PubMed

Insights

Cardiovascular risk factors were assessed in multiple sclerosis patients, revealing elevated risks in males and those with advanced disease. Early identification and management are crucial for this population.

Area of Science:

  • Neurology
  • Cardiology
  • Public Health

Background:

  • Multiple sclerosis (MS) patients face increased risks for cardiovascular diseases (CVDs).
  • Identifying specific cardiovascular risk factors in MS populations is essential for proactive healthcare.
  • This study examines CVD risk factors in a Romanian cohort of MS patients.

Purpose of the Study:

  • To identify prevalent cardiovascular risk factors in 91 patients diagnosed with multiple sclerosis.
  • To assess the average cardiovascular risk score within this specific patient group.
  • To determine demographic and disease-related factors associated with higher cardiovascular risk.

Main Methods:

  • Retrospective analysis of medical records and self-administered questionnaires.
  • Evaluation of parameters including smoking status, body mass index (BMI), blood sugar, cholesterol, triglycerides, and blood pressure.
  • Calculation of average cardiovascular risk using established risk assessment models.

Main Results:

  • Average BMI was 23.89 kg/m², with 41.76% outside normal limits. Smoking prevalence varied, with former smokers being the largest group.
  • Elevated fasting blood glucose (>126 mg/dL) was observed in 25.27% of patients; 11 patients had hypertension (HTA).
  • Average cardiovascular risk was 6.61%, higher in males, rural patients, and those with secondary-progressive MS or disease duration over 10 years.

Conclusions:

  • Multiple sclerosis patients exhibit various cardiovascular risk factors that warrant attention.
  • Specific subgroups, including males and those with advanced MS, are at higher cardiovascular risk.
  • Proactive screening and management of cardiovascular risk factors are vital for improving outcomes in multiple sclerosis patients.

Related Concept Videos

Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
248
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
22
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
39